Pharmacy Medical Policy Updates
The following Pharmacy Medical Policy program has been updated March 1, 2023:
Effective April 1, 2023:
- Ampyra
- Multiple Sclerosis
- Healthcare Administered Multiple Sclerosis
- Kerendia
- Opzelura
- Spinraza
- SA Oncology
- Tezspire
- Zeposia
Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.
To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.
If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.